重症医学会指南:识别与应对ICU外临床恶化(2023)
该指南由25人专家组(含医学、护理、呼吸治疗、药学、患者/家属伙伴及方法学专家)制定,采用PICO格式生成问题、系统评价文献,并用GRADE方法确定证据确定性、形成推荐和良好实践声明(GPS)。共发布10条关于识别与应对非ICU危重患者的声明:医护人员和机构应确保所有生命体征采集及时准确(GPS);对未选择患者使用连续生命体征监测不作推荐;建议对床旁临床医生进行临床恶化征象的集中教育,并建议将患者/家属/照护伙伴的担忧纳入获取额外意见和帮助的决策(均为条件推荐);推荐医院范围内部署具有明确启动标准的快速反应团队/医疗应急团队(RRT/MET)(强推荐);对RRT/MET专业构成或响应团队是否纳入姑息治疗成员不作推荐,但建议响应者的技能组合应包括引出患者照护目标(条件推荐);质量改进流程应成为快速反应系统的一部分。
要点
- 推荐医院范围内部署具有明确启动标准的快速反应团队/医疗应急团队(RRT/MET)(强推荐)。
- 医护人员和机构应确保所有生命体征采集及时准确(良好实践声明,GPS)。
- 建议对床旁临床医生进行临床恶化征象的集中教育(条件推荐)。
- 建议将患者/家属/照护伙伴的担忧纳入获取额外意见和帮助的决策(条件推荐)。
- 建议响应者的技能组合应包括引出患者照护目标(条件推荐);质量改进流程应成为快速反应系统的一部分。
适用人群与场景
- 住院的非ICU患者,即ICU外临床恶化风险患者。
处置流程与药物剂量
- 医院范围内部署快速反应团队或医疗应急团队(RRT/MET),并制定明确的启动标准(强推荐)。
- 确保所有生命体征采集及时且准确(良好实践声明,GPS)。
- 对床旁临床医生进行临床恶化征象的集中教育(条件推荐)。
- 将患者/家属/照护伙伴的担忧纳入获取额外意见和帮助的决策(条件推荐)。
- 响应者的技能组合应包括引出患者的照护目标(条件推荐)。
- 质量改进流程应成为快速反应系统的一部分。
研究设计与关键结果
- 专家组共发布10条关于识别与应对非ICU危重患者的声明。
- 对未选择患者使用连续生命体征监测不作推荐。
- 对RRT/MET的专业构成或响应团队是否纳入姑息治疗成员不作推荐。
证据类型、等级与局限
- 证据类型:指南(重症医学会,2023),采用GRADE方法确定证据确定性并形成推荐和良好实践声明(GPS)。
- 推荐强度:医院范围内部署RRT/MET为强推荐;集中教育、纳入患者/家属/照护伙伴担忧、响应者技能包括引出照护目标均为条件推荐;生命体征采集及时准确为良好实践声明(GPS)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 医院应部署具有明确启动标准的RRT/MET(强推荐),并确保生命体征采集及时准确(GPS)。
- 对床旁临床医生进行临床恶化征象的集中教育(条件推荐),并将患者/家属/照护伙伴的担忧纳入获取额外意见和帮助的决策(条件推荐)。
- 响应者技能组合应包括引出患者照护目标(条件推荐);质量改进流程应成为快速反应系统的一部分。
- 对未选择患者使用连续生命体征监测不作推荐;对RRT/MET专业构成或纳入姑息治疗成员不作推荐。
指南或共识出处
- Society of Critical Care Medicine Guidelines on Recognizing and Responding to Clinical Deterioration Outside the ICU: 2023(重症医学会,2023)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: Clinical deterioration of patients hospitalized outside the ICU is a source of potentially reversible morbidity and mortality. To address this, some acute care hospitals have implemented systems aimed at detecting and responding to such patients.
OBJECTIVES: To provide evidence-based recommendations for hospital clinicians and administrators to optimize recognition and response to clinical deterioration in non-ICU patients.
PANEL DESIGN: The 25-member panel included representatives from medicine, nursing, respiratory therapy, pharmacy, patient/family partners, and clinician-methodologists with expertise in developing evidence-based Clinical Practice Guidelines.
METHODS: We generated actionable questions using the Population, Intervention, Control, and Outcomes (PICO) format and performed a systematic review of the literature to identify and synthesize the best available evidence. We used the Grading of Recommendations Assessment, Development, and Evaluation Approach to determine certainty in the evidence and to formulate recommendations and good practice statements (GPSs).
RESULTS: The panel issued 10 statements on recognizing and responding to non-ICU patients with critical illness. Healthcare personnel and institutions should ensure that all vital sign acquisition is timely and accurate (GPS). We make no recommendation on the use of continuous vital sign monitoring among unselected patients. We suggest focused education for bedside clinicians in signs of clinical deterioration, and we also suggest that patient/family/care partners' concerns be included in decisions to obtain additional opinions and help (both conditional recommendations). We recommend hospital-wide deployment of a rapid response team or medical emergency team (RRT/MET) with explicit activation criteria (strong recommendation). We make no recommendation about RRT/MET professional composition or inclusion of palliative care members on the responding team but suggest that the skill set of responders should include eliciting patients' goals of care (conditional recommendation). Finally, quality improvement processes should be part of a rapid response system.
CONCLUSIONS: The panel provided guidance to inform clinicians and administrators on effective processes to improve the care of patients at-risk for developing critical illness outside the ICU.
参考来源
- Honarmand K, Wax RS, Penoyer D, et al. Society of Critical Care Medicine Guidelines on Recognizing and Responding to Clinical Deterioration Outside the ICU: 2023. Crit Care Med. 2024. PMID: 38240510. doi:10.1097/CCM.0000000000006072
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。